Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block listing Interim Review

20 Feb 2017 07:00

RNS Number : 8347W
Realm Therapeutics PLC
20 February 2017
 

Realm Therapeutics plc

Block Listing Interim Review

 

Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies Realm Therapeutics plc makes the following update on its block listing:

 

Date: 20 February 2017

 

Name of applicant:

Realm Therapeutics plc

Name of scheme:

Executive Omnibus Incentive Plan

Warrants

Figures for all schemes relate to ordinary shares

of 10 pence each

Period of return:

From: 18 August 2016 To: 17 February 2017

Balance of unallotted securities under scheme(s) from previous return:

2,085,362

117,195

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Nil

Less: Number of securities issued/allotted under scheme(s) during period:

30,000

Nil

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

2,055,362

117,195

 

 

Number and class of securities originally admitted:

 

* these securities have been adjusted for a 1 for 10 share consolidation which took effect on 2 July 2010

*20,000 and

*378,423 + *32,000 and 200,000

*196,087 and

*21,108

Dates of Admission:

 

7 August 2006 and 31 August 2007 and 15 August 2012

7 August 2006 and

31 August 2007

Name of contact:

Marella Thorell, Company Secretary

Telephone number of contact:

+1 484-321-2749

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRBDGDDDDBBGRR
Date   Source Headline
30th Jul 20087:04 amRNSPuriCore Wins Food Safety Con
30th Jul 20087:02 amRNSTrading Update
30th Jul 20087:00 amRNSPlacing and Open Offer
2nd Jul 20087:00 amRNSAwarded Contract
1st Jul 20087:00 amRNSPatent Decision and Debt Fina
26th Jun 200811:34 amRNSAGM Statement
19th Jun 20087:00 amRNSPiper Jaffray European Confer
9th Jun 20087:00 amRNSNatural Resources & Infrastru
2nd Jun 20087:00 amRNSAnnual Report and Accounts
27th May 20087:00 amRNSAnnual Information Update
20th May 20083:48 pmRNSHolding(s) in Company
14th May 200812:19 pmRNSHolding(s) in Company
13th May 20089:07 amRNSDirector/PDMR Shareholding
1st May 200810:06 amRNSDirector/PDMR Shareholding
30th Apr 20084:01 pmRNSDirector/PDMR Shareholding
29th Apr 20087:01 amRNSInterim Management Statement
29th Apr 20087:01 amRNSFinal Results
23rd Apr 20087:01 amRNSPresent Clinical Data
3rd Apr 20087:00 amRNSNotice of Results
21st Feb 20084:20 pmRNSNotice of Interest in Shares
21st Feb 20087:01 amRNSDirector/PDMR Shareholding
20th Feb 20087:01 amRNSTrading Update
20th Feb 20087:01 amRNSAcquisition Agreement for IP
8th Feb 20082:26 pmRNSHolding(s) in Company
6th Feb 20088:31 amRNSBlocklisting Interim Review
6th Feb 20088:04 amRNSSenior Independent Director
1st Feb 20088:48 amRNSVoting rights
23rd Jan 20087:00 amRNSResearch Update
11th Jan 20087:00 amRNSRe: Food Retail Contract
21st Dec 200711:36 amRNSHolding(s) in Company
10th Dec 20077:01 amRNSAdditional US Patent
23rd Nov 20075:52 pmRNSHolding(s) in Company
25th Oct 200712:00 pmBUSPuriCore Presenting at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
25th Oct 20077:00 amRNSPresenting at Conference
17th Oct 200712:00 pmBUSPuriCore Arranges New $20 Million Borrowing Facility
17th Oct 20077:00 amRNSArranges Borrowing Facility
12th Oct 20078:46 amRNSFCSI Product of the Year
11th Oct 20074:35 pmBUSSterilox Food Safety System Named FCSI Product of the Year
8th Oct 200712:00 pmBUSPuriCore Receives US Patent on Wound Therapy Method
8th Oct 20077:00 amRNSReceives US Patent
24th Sep 20077:03 amRNSRe: Wound Therapy System
24th Sep 20077:01 amRNSInterim Results
5th Sep 20074:14 pmRNSHolding(s) in Company
4th Sep 20077:01 amRNSBlocklisting Applications
31st Aug 20077:01 amRNSBlocklisting Interim Review
24th Jul 20076:24 pmRNSHolding(s) in Company
24th Jul 20079:32 amRNSDirector's Interest
23rd Jul 20077:01 amRNSTrading Update
18th Jun 200712:00 pmBUSAdditional Studies Demonstrate PuriCore's Sterilox Solution Effective against Major Outbreak Pathogens
18th Jun 20077:02 amRNSResearch Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.